Publicaciones en colaboración con investigadores/as de Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (40)

2021

  1. Abnormal liver function test in patients infected with coronavirus (Sars-cov-2): A retrospective single-center study from spain

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-18

  2. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey

    Clinical Nutrition ESPEN, Vol. 45, pp. 433-441

  3. Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study

    Journal of Psychosomatic Research, Vol. 140

  4. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study

    Journal of Hepatology, Vol. 75, Núm. 5, pp. 1026-1033

  5. Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies

    HIV Research and Clinical Practice, Vol. 23, Núm. 1, pp. 9-14

  6. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

    The Lancet Neurology, Vol. 20, Núm. 1, pp. 49-59

  7. Normal values and regional differences in oesophageal impedance-pH metrics: A consensus analysis of impedance-pH studies from around the world

    Gut, Vol. 70, Núm. 8, pp. 1441-1449

  8. Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring

    Kidney International, Vol. 99, Núm. 1, pp. 227-237

  9. SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients

    Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2946-2957

  10. The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial

    Trials, Vol. 22, Núm. 1